The Journal of Organic Chemistry
Article
mixture was quenched with saturated aqueous NaHCO and extracted
3
with AcOEt three times. The combined organic layers were washed
with brine, dried over Na SO , and concentrated in vacuo. The
2
4
(
CH ), 31.6 (CH ), 37.1 (CH ), 37.8 (C), 39.6 (CH), 42.0 (CH ),
residue was purified with silica gel column chromatography (hexane/
AcOEt = 3:1) to afford 29 (291 mg, 68%) as a white solid.
3
3
2
2
4
1
1
4
3.6 (C), 44.6 (CH), 46.9 (CH ), 70.0 (C), 73.9 (CH), 139.4 (C),
2
53.6 (CH), 193.3 (CH). IR (neat): 3526, 2943, 2866, 1697, 1462,
R 0.28 (hexane/AcOEt = 3:1).
f
+
1
149, 1041. HRMS−ESI (m/z): [M + Na] calcd for C H NaO Si,
H NMR: 1.01 (s, 3H), 1.02 (s, 3H), 1.20 (s, 3H), 1.27−1.33 (m,
5H), 1.45 (dd, J = 7.0, 12.5 Hz, 1H), 1.55 (dd, J = 2.0, 13.5 Hz, 1H),
1.88 (dd, J = 8.5, 11.5 Hz, 1H), 1.92 (dd, J = 9.5, 13.5 Hz, 1H), 2.14
(ddd, J = 7.0, 7.5, 12.5 Hz, 1H), 2.63 (br, 1H, OH), 2.86 (tdd, J = 2.0,
7.5, 9.5 Hz, 1H), 2.94 (qd, J = 7.5, 13.5 Hz, 1H), 2.97 (qd, J = 7.5,
13.5 Hz, 1H), 3.80 (br, 1H, OH), 4.41 (t, J = 8.5 Hz, 1H), 6.98 (d, J
2
4
42
3
29.2801; found, 429.2802.
S-Ethyl (2S*,2aS*,4aS*,7aS*,7bR*)-2,2a-Dihydroxy-6,6,7b-tri-
methyl-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene-3-
carbothioate (27). To a solution of 26d (200 mg, 0.43 mmol) in
THF (10 mL) were added NH F (36 mg, 0.97 mmol) and tetra-n-
butylammonium fluoride (1.0 M in THF, 0.77 mL, 0.77 mmol) at 0
4
1
3
= 2.0 Hz, 1H). C NMR: 14.5 (CH ), 22.0 (CH ), 23.5 (CH ), 31.2
3 3 2
°
C. The mixture was stirred for 1 h at the same temperature,
quenched with saturated aqueous NH Cl, and extracted with AcOEt
(CH ), 31.6 (CH ), 34.5 (CH ), 36.7 (C), 37.8 (C), 39.7 (CH), 41.7
3 3 2
4
(CH ), 43.8 (CH), 46.8 (CH ), 76.1 (CH), 136.1 (C), 145.9 (CH),
2
2
three times. The combined organic layers were washed with brine,
dried over Na SO , and concentrated in vacuo. The residue was
purified with silica gel column chromatography (hexane/AcOEt =
198.1 (C). IR (neat): 3449, 2947, 2866, 1643, 1447, 1377, 1204,
+
2
4
1080, 980, 768. HRMS−ESI (m/z): [M + Na] calcd for
C H NaO S, 333.1495; found, 333.1498. mp: 80−82 °C.
1
7
26
3
5
:1−3:1) to afford 27 (120 mg, 91%) as a white solid.
X-ray crystallographic analysis (CCDC 1905934): recrystallization
R 0.40 (hexane/AcOEt = 3:1).
from hot hexane gave colorless platelets suitable for X-ray crystal
structural analysis: triclinic P1; a = 8.372 (6), b = 9.957 (7), c =
f
1
H NMR: 1.00 (s, 3H), 1.02 (s, 3H), 1.28 (t, J = 7.5 Hz, 3H), 1.29
̅
(
1
(
t, J = 12.5 Hz. 1H), 1.31 (s, 3H), 1.44 (dd, J = 7.0, 12.5 Hz, 1H),
.48 (dd, J = 0.5, 13.0 Hz, 1H), 1.58 (dd, J = 1.5, 13.0 Hz, 1H), 1.78
dd, J = 6.0, 13.0 Hz, 1H), 1.92 (dd, J = 9.0, 13.0 Hz, 1H), 2.04 (ddd,
10.205 (6); α = 94.49 (5), β = 102.94 (5), γ = 99.05 (5); V = 813.1
(10), Z = 2, D = 1.27.
x
Compound 30. To a solution of 29 (100 mg, 0.322 mmol) in 1,2-
dichloroethane (2.0 mL) were added DMAP (197 mg, 1.61 mmol),
EDCI·HCl (309 mg, 1.61 mmol), and orsellinic acid (271 mg, 1.61
mmol) at room temperature. After stirring for 25.5 h at 60 °C (oil
bath), the reaction mixture was quenched with saturated aqueous
J = 7.0, 7.5, 12.5 Hz, 1H), 2.76−2.79 (m, 1H), 2.91 (qd, J = 7.5, 13.5
Hz, 1H), 2.95 (qd, J = 7.5, 13.5 Hz, 1H), 3.32 (br, 1H, OH), 3.96−
1
3
3
.98 (m, 1H), 4.18 (s, 1H, OH), 6.84−6.85 (m, 1H). C NMR: 14.5
(
(
(
(
CH ), 22.5 (CH ), 23.3 (CH ), 31.5 (CH ), 31.7 (CH ), 35.7
3 3 2 3 3
CH ), 37.7 (C), 39.6 (CH), 41.9 (CH ), 43.5 (C), 44.5 (CH), 47.1
CH ), 71.2 (C), 73.0 (CH), 138.0 (C), 144.8 (CH), 195.6 (C). IR
neat): 3464, 2943, 1651, 1454, 1138, 910. HRMS−ESI (m/z): [M +
Na] calcd for C H NaO S, 333.1495; found, 333.1497. mp: 108−
NH
4
Cl and extracted with AcOEt three times. The combined organic
SO , and concentrated
2
2
layers were washed with brine, dried over Na
2
2
4
in vacuo. The residue was purified with silica gel column
chromatography (hexane/AcOEt = 3:1), followed by HPLC (YMC
Multiple Preparative HPLC LC-forte/R, YMC-GPC T2000) to afford
30 (94 mg, 62%) as a white solid.
+
17
26
3
1
10 °C.
X-ray crystallographic analysis (CCDC 1905933): recrystallization
from hot hexane gave colorless platelets suitable for X-ray crystal
R 0.76 (hexane/AcOEt = 1:1).
f
1
structural analysis: monoclinic, P2 /c; a = 11.968 (2), b = 12.136 (3),
H NMR: 0.92 (t, J = 7.5 Hz, 3H), 1.00 (s, 3H), 1.01 (s, 3H), 1.32
(s, 3H), 1.35 (dd, J = 12.5, 13.0 Hz, 1H), 1.49 (dd, J = 7.0, 12.5 Hz,
1H), 1.55 (dd, J = 2.5, 13.5 Hz, 1H), 1.66 (dd, J = 9.0, 11.0 Hz, 1H),
1.96 (dd, J = 9.5, 13.5 Hz, 1H), 1.98 (dd, J = 9.0, 11.0 Hz, 1H), 2.23
(ddd, J = 7.0, 7.0, 12.5 Hz, 1H), 2.38 (s, 3H), 2.56 (qd, J = 7.5, 13.5
Hz, 1H), 2.60 (qd, J = 7.5, 13.5 Hz, 1H), 2.92 (dddd, J = 1.5, 2.5, 7.0,
9.5 Hz, 1H), 4.89 (s, 1H, OH), 5.60 (br, 1H, OH), 5.70 (dd, J = 9.0,
9.0 Hz, 1H), 6.16 (d, J = 2.0 Hz, 1H), 6.25 (d, J = 2.0 Hz, 1H), 7.00
1
c = 11.618 (3); β = 95.415 (2); V = 1680.0 (7), Z = 4, D = 1.23.
x
S-Ethyl (2aS*,4aS*,7aS*,7bR*)-2a-Hydroxy-6,6,7b-trimethyl-2-
oxo-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene-3-car-
bothioate (28). To a solution of N-chlorosuccinimide (123 mg, 0.92
mmol) in toluene (5.0 mL) was added a solution of dimethyl sulfide
(1.0 M in toluene, 1.1 mL, 1.1 mmol) at −20 °C. After the mixture
was stirred for 40 min at the same temperature, to this was added a
solution of 27 (191 mg, 0.62 mmol) in toluene (5.0 mL). After the
resulting mixture was stirred for 40 min, triethylamine (0.26 mL, 1.9
mmol) was added. The mixture was stirred for an additional 1 h at 0
1
3
(d, J = 1.5 Hz, 1H), 11.75 (s, 1H, OH). C NMR: 13.9 (CH ), 21.6
3
(CH ), 23.1 (CH ), 24.4 (CH ), 31.0 (CH ), 31.4 (CH ), 32.3
3
2
3
3
3
(CH ), 37.7 (C), 37.9 (C), 39.6 (CH), 41.7 (CH ), 43.4 (CH), 46.6
2
2
°
C, quenched with water, and extracted with hexane three times. The
(CH ), 76.6 (CH), 76.9 (C), 101.1 (CH), 105.1 (C), 111.3 (CH),
134.4 (C), 144.1 (C), 145.9 (CH), 160.7 (C), 165.4 (C), 170.8 (C),
2
combined organic layers were washed with brine, dried over Na SO ,
2
4
and concentrated in vacuo. The residue was purified with silica gel
column chromatography (hexane/AcOEt = 10:1−5:1) to afford 28
196.2 (C). IR (neat): 3356, 2951, 1651, 1447, 1311, 1257, 1099, 733.
+
HRMS−ESI (m/z): [M + Na] calcd for C25
H32NaO S, 483.1812;
6
(
165 mg, 87%) as a white solid.
found, 483.1809. mp: 190−193 °C.
R 0.40 (hexane/AcOEt = 3:1).
Melleolide (1). To a solution of 30 (20 mg, 43 μmol) in CH
Cl
2
2
f
1
H NMR: 1.05 (s, 3H), 1.06 (s, 3H), 1.22 (s, 3H), 1.28 (t, J = 7.5
(5.0 mL) were added Pd/C (10 wt %, 46 mg, 43 μmol), MgSO
4
(105
Hz, 1H), 1.36 (t, J = 13.0 Hz, 1H), 1.59 (dd, J = 7.0, 13.0 Hz, 1H),
.65 (dd, J = 2.0, 13.5 Hz, 1H), 2.05 (dd, J = 9.5, 13.5 Hz, 1H), 2.41
d, J = 16.0 Hz, 1H), 2.48 (ddd, J = 7.0, 7.5, 13.0 Hz, 1H), 2.79 (d, J
mg, 0.868 mmol), and triethylsilane (35 μL, 0.22 mmol) at room
temperature. After stirring for 1.5 h at the same temperature, the
mixture was filtered through a pad of Celite. The filtered residue was
1
(
=
=
16.0 Hz, 1H), 2.92 (dddd, J = 2.0, 2.5, 7.5, 9.5 Hz, 1H), 2.94 (qd, J
7.5, 13.5 Hz, 1H), 2.97 (qd, J = 7.5, 13.5 Hz, 1H), 4.61 (s, 1H,
washed with Et O several times. The filtrate was concentrated in
2
vacuo to give the residue, which was purified with silica gel column
chromatography (hexane/AcOEt = 3:1) to afford melleolide (1) (15
mg, 88%) as a white solid.
1
3
OH), 7.01 (d, J = 2.5 Hz, 1H). C NMR: 14.5 (CH ), 20.4 (CH ),
3
3
3.4 (CH ), 31.2 (CH ), 31.6 (CH ), 36.5 (C), 38.4 (C), 39.8 (CH),
2 3 3
2.0 (CH), 42.6 (CH ), 46.5 (CH ), 51.7 (CH ), 86.3 (C), 131.9
R 0.16 (hexane/AcOEt = 3:1).
f
2
2
2
1
H NMR: 1.00 (s, 3H), 1.03 (s, 3H), 1.29 (dd, J = 13.0, 13.0 Hz,
1H), 1.33 (s, 3H), 1.50 (dd, J = 7.0, 12.5 Hz, 1H), 1.58 (dd, J = 9.0,
11.5 Hz, 1H), 1.59 (dd, J = 3.0, 13.5 Hz, 1H), 2.02 (dd, J = 9.5, 13.5
Hz, 1H), 2.07 (dd, J = 8.5, 11.5 Hz, 1H), 2.28 (ddd, J = 7.0, 7.0, 13.0
Hz, 1H), 2.28 (s, 3H), 3.03 (dddd, J = 2.0, 3.0, 7.0, 9.5 Hz, 1H), 4.47
(s, 1H, OH), 5.66 (dd, J = 8.5, 9.0 Hz, 1H), 6.14 (d, J = 2.0 Hz, 1H),
6.14 (br, 1H, OH), 6.20 (d, J = 2.0 Hz, 1H), 6.82 (d, J = 2.0 Hz, 1H),
2
866, 1782, 1636, 1450, 1377, 1173, 1103, 764. HRMS−ESI (m/z):
+
[
M + Na] calcd for C H NaO S, 331.1338; found, 331.1336. mp:
17 24 3
8
3−85 °C.
(
S)-Ethyl (2R*,2aS*,4aS*,7aS*,7bR*)-2,2a-Dihydroxy-6,6,7b-tri-
methyl-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene-3-
carbothioate (29). To a solution of 28 (426 mg, 1.4 mmol) in
CH Cl (30 mL) was added sodium triacetoxyborohydride (1.5 g, 6.9
1
9.47 (s, 1H), 11.64 (s, 1H, OH). H NMR (CD Cl ): 0.99 (s, 3H),
2
2
2
2
mmol) at 0 °C. After stirring for 7.5 h at room temperature, the
1.02 (s, 3H), 1.26 (dd, J = 13.0, 13.5 Hz, 1H), 1.30 (s, 3H), 1.49 (dd,
H
J. Org. Chem. XXXX, XXX, XXX−XXX